Elekta AB (EKTAY)
7.67
+0.05
(+0.66%)
USD |
OTCM |
May 16, 16:00
Elekta Price to Book Value: 2.976 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.976 |
| May 15, 2024 | 2.956 |
| May 14, 2024 | 2.916 |
| May 13, 2024 | 2.898 |
| May 10, 2024 | 2.858 |
| May 09, 2024 | 2.776 |
| May 08, 2024 | 2.811 |
| May 07, 2024 | 2.815 |
| May 06, 2024 | 2.821 |
| May 03, 2024 | 2.743 |
| May 02, 2024 | 2.726 |
| May 01, 2024 | 2.731 |
| April 30, 2024 | 2.797 |
| April 29, 2024 | 2.780 |
| April 26, 2024 | 2.660 |
| April 25, 2024 | 2.600 |
| April 24, 2024 | 2.685 |
| April 23, 2024 | 2.735 |
| April 22, 2024 | 2.691 |
| April 19, 2024 | 2.611 |
| April 18, 2024 | 2.629 |
| April 17, 2024 | 2.666 |
| April 16, 2024 | 2.704 |
| April 15, 2024 | 2.751 |
| April 12, 2024 | 2.724 |
| Date | Value |
|---|---|
| April 11, 2024 | 2.838 |
| April 10, 2024 | 2.871 |
| April 09, 2024 | 2.956 |
| April 08, 2024 | 3.033 |
| April 05, 2024 | 2.974 |
| April 04, 2024 | 3.003 |
| April 03, 2024 | 3.028 |
| April 02, 2024 | 2.973 |
| April 01, 2024 | 2.939 |
| March 28, 2024 | 2.914 |
| March 27, 2024 | 2.937 |
| March 26, 2024 | 2.935 |
| March 25, 2024 | 2.938 |
| March 22, 2024 | 2.922 |
| March 21, 2024 | 2.924 |
| March 20, 2024 | 2.908 |
| March 19, 2024 | 2.933 |
| March 18, 2024 | 2.914 |
| March 15, 2024 | 2.962 |
| March 14, 2024 | 2.916 |
| March 13, 2024 | 2.915 |
| March 12, 2024 | 2.922 |
| March 11, 2024 | 2.872 |
| March 08, 2024 | 2.884 |
| March 07, 2024 | 2.925 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.995
Minimum
Sep 27 2022
6.883
Maximum
Nov 14 2019
4.224
Average
4.243
Median
Jun 22 2020
Price to Book Value Benchmarks
| Abliva AB | 1.914 |
| Karolinska Development AB | 0.5938 |
| Calliditas Therapeutics AB | 17.78 |
| Oncopeptides AB | 1.961 |
| Olink Holding AB | 6.451 |
Price to Book Value Related Metrics
| PE Ratio | 21.60 |
| PS Ratio | 1.704 |
| PEG Ratio | 0.33 |
| Price to Free Cash Flow | 20.19 |
| Price | 7.67 |
| Earnings Yield | 4.63% |
| Market Cap | 2.931B |
| PEGY Ratio | 0.3158 |
| Operating PE Ratio | 12.53 |
| Normalized PE Ratio | 21.60 |